Johnson & Johnson: Update following ratings affirmation

Our credit view of this issuer reflects its strong global scale and diversity and conservative financial policies, offset by unresolved talc litigation exposures.

Shockwave Being Bought by Johnson & Johnson for $335

Moody's Ratings affirms J&J's Aaa ratings; stable outlook

Moody's Ratings (Moody's) affirmed the ratings of Johnson & Johnson ("J&J") including the Aaa long-term issuer rating, Aaa senior unsecured rating, (P)Aaa senior unsecured medium term note program rating and Prime-1 commercial paper rating. The outlook remains stable. This rating action follows th...

Johnson & Johnson - December 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Zoetis Inc.: Update to credit analysis following outlook change to pos...

Our credit view of this issuer reflects its status as a largest manufacturer of pharmaceuticals for animal health, constrained by its exposure to generic competition.

Moody's revises Zoetis' outlook to positive from stable; affirms Baa1 ...

Moody's Ratings (Moody's) affirmed the ratings of Zoetis Inc. ("Zoetis"), including the Baa1 senior unsecured rating and the Prime-2 commercial paper rating. At the same time, Moody's revised the outlook to positive from stable. The revision in Zoetis' outlook to positive reflects Zoetis continued...

Johnson & Johnson: 1 director

A director at Johnson & Johnson sold 8,891 shares at 162.160USD and the significance rating of the trade was 79/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

Zoetis Inc. - December 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Saponia dd - Company Profile and SWOT Analysis

Summary Saponia dd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Saponia dd (Saponia) is a manufacturer of home care and personal hygiene products. The company’s product portfolio comprises dish detergents, laundry detergents, toothbrushes, baby care, hand cream, shaving ...

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

More Upside Expected; Upgrading Health Care Since early November 2023 we have laid out our bullish expectations for a year-end rally that we discussed would continue into the early part of 2024. Here we are in the early part of 2024, and we see every reason to continue riding this bull market higher. Bullish Outlook Intact. The S&P 500, Nasdaq 100, and DJI are breaking out to new all-time highs, while the small-cap Russell 2000 (IWM), mid-cap S&P 400 (IJH), Vanguard Extended Market ETF (VXF), ...

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Bullish Outlook Intact; Downgrading Communications The market remains in "lockout rally" mode, where prices continue to move higher with little-to-no pullbacks, while ignoring overbought readings. There is no reason to fight this bullish trend, and we continue to expect a rally into year-end and the early part of 2024. Lockout Rally Continues. In our 12/4/23 ETF Pathfinder we discussed how this is a very strong market that is not likely to pull back -- and the surge higher has continued. The S...

Zoetis Inc: 1 director

A director at Zoetis Inc sold 2,500 shares at 200.000USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

Zoetis Inc. - September 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Johnson & Johnson - October 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

ETF Pathfinder: Expecting More Upside Ahead; Upgrading Cap-Weighted Technology (XLK) and Communications (XLC) to Overweight; Downgrading Health Care (XLV) to Underweight

Johnson & Johnson: Solid operating performance and pipeline execution,...

Our credit view of this issuer reflects its strong scale, diversity, profit margins and cash flow, offset by unresolved legal exposures and event risk associated with acquisitions.

Zoetis Inc. - June 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Johnson & Johnson - July 2023 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Zoetis Inc.: Update to credit analysis

Our credit view of this issuer reflects its status as the largest manufacturer of pharmaceuticals for animal health, against its exposure to generic competition in the near-term.

Moody's: New setback in J&J talc litigation raises uncertainty

Moody's Investors Service commented that the recent setback in Johnson & Johnson's (Aaa stable) efforts to resolve outstanding talc litigation is credit negative. A federal judge dismissed the bankruptcy filing by J&J's subsidiary LTL Management LLC (LTL). This process would significantly reduce the...